359 related articles for article (PubMed ID: 31278430)
1. Resolution of ulcerative colitis.
Neurath MF; Leppkes M
Semin Immunopathol; 2019 Nov; 41(6):747-756. PubMed ID: 31278430
[TBL] [Abstract][Full Text] [Related]
2. Acute Experimental Barrier Injury Triggers Ulcerative Colitis-Specific Innate Hyperresponsiveness and Ulcerative Colitis-Type Microbiome Changes in Humans.
Seidelin JB; Bahl MI; Licht TR; Mead BE; Karp JM; Johansen JV; Riis LB; Galera MR; Woetmann A; Bjerrum JT
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1281-1296. PubMed ID: 34118489
[TBL] [Abstract][Full Text] [Related]
3. Cross Talk between Gut Microbiota and Intestinal Mucosal Immunity in the Development of Ulcerative Colitis.
Zou J; Liu C; Jiang S; Qian D; Duan J
Infect Immun; 2021 Aug; 89(9):e0001421. PubMed ID: 33526559
[TBL] [Abstract][Full Text] [Related]
4. Ulcerative colitis: an epithelial disease?
Gibson PR
Baillieres Clin Gastroenterol; 1997 Mar; 11(1):17-33. PubMed ID: 9192058
[TBL] [Abstract][Full Text] [Related]
5. Intestinal production of secreted protein acidic and rich in cysteine (SPARC) in patients with ulcerative colitis.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Razo-López N; Barreto-Zúñiga R; Martínez-Benítez B; Yamamoto-Furusho JK
Immunobiology; 2021 May; 226(3):152095. PubMed ID: 34000572
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer.
Yao D; Dong M; Dai C; Wu S
Inflamm Bowel Dis; 2019 Sep; 25(10):1595-1602. PubMed ID: 31287863
[TBL] [Abstract][Full Text] [Related]
7. Ulcerative colitis.
Ungaro R; Mehandru S; Allen PB; Peyrin-Biroulet L; Colombel JF
Lancet; 2017 Apr; 389(10080):1756-1770. PubMed ID: 27914657
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis.
Soendergaard C; Kvist PH; Thygesen P; Reslow M; Nielsen OH; Kopchick JJ; Holm TL
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946616
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.
Muthas D; Reznichenko A; Balendran CA; Böttcher G; Clausen IG; Kärrman Mårdh C; Ottosson T; Uddin M; MacDonald TT; Danese S; Berner Hansen M
Scand J Gastroenterol; 2017 Feb; 52(2):125-135. PubMed ID: 27610713
[TBL] [Abstract][Full Text] [Related]
10. Immune response and inflammatory pathway of ulcerative colitis.
Tatiya-Aphiradee N; Chatuphonprasert W; Jarukamjorn K
J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):1-10. PubMed ID: 30063466
[TBL] [Abstract][Full Text] [Related]
11. COX-2-PGE
Li Y; Soendergaard C; Bergenheim FH; Aronoff DM; Milne G; Riis LB; Seidelin JB; Jensen KB; Nielsen OH
EBioMedicine; 2018 Oct; 36():497-507. PubMed ID: 30190207
[TBL] [Abstract][Full Text] [Related]
12. Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis.
Sham HP; Bazett M; Bosiljcic M; Yang H; Luk B; Law HT; Morampudi V; Yu HB; Pankovich J; Sutcliffe S; Bressler B; Marshall JK; Fedorak RN; Chen J; Jones M; Gunn H; Kalyan S; Vallance BA
Front Immunol; 2018; 9():2211. PubMed ID: 30319652
[No Abstract] [Full Text] [Related]
13. Can ulcerative colitis be cured?
Pravda J
Discov Med; 2019 May; 27(149):197-200. PubMed ID: 31361982
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease: the surgical pathology of Crohn's disease and ulcerative colitis.
Price AB; Morson BC
Hum Pathol; 1975 Jan; 6(1):7-29. PubMed ID: 1089084
[TBL] [Abstract][Full Text] [Related]
15. Mucosal healing in ulcerative colitis: where do we stand?
Fiorino G; Cesarini M; Indriolo A; Malesci A
Curr Drug Targets; 2011 Sep; 12(10):1417-23. PubMed ID: 21466490
[TBL] [Abstract][Full Text] [Related]
16. Mucosal healing progression after acute colitis in mice.
Vidal-Lletjós S; Andriamihaja M; Blais A; Grauso M; Lepage P; Davila AM; Gaudichon C; Leclerc M; Blachier F; Lan A
World J Gastroenterol; 2019 Jul; 25(27):3572-3589. PubMed ID: 31367158
[TBL] [Abstract][Full Text] [Related]
17. Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis.
Fang J; Wang H; Zhou Y; Zhang H; Zhou H; Zhang X
Exp Mol Med; 2021 May; 53(5):772-787. PubMed ID: 34002011
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.
Babyatsky MW; Rossiter G; Podolsky DK
Gastroenterology; 1996 Apr; 110(4):975-84. PubMed ID: 8613031
[TBL] [Abstract][Full Text] [Related]
20. Th9 Cells: Probable players in ulcerative colitis pathogenesis.
Shohan M; Elahi S; Shirzad H; Rafieian-Kopaei M; Bagheri N; Soltani E
Int Rev Immunol; 2018; 37(4):192-205. PubMed ID: 29672174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
